Stroke genetics: discovery, biology, and clinical applications

被引:125
|
作者
Dichgans, Martin [1 ,2 ,3 ]
Pulit, Sara L. [4 ,5 ,6 ]
Rosand, Jonathan [6 ,7 ,8 ]
机构
[1] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany
[2] German Ctr Neurodegenerat Dis, Munich, Germany
[3] Munich Cluster Syst Neurol SyNergy, Munich, Germany
[4] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Genet, Utrecht, Netherlands
[5] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Big Data Inst, Oxford, England
[6] Broad Inst, Program Med Populat & Genet, Cambridge, MA USA
[7] Massachusetts Gen Hosp, Henry & Allison McCance Ctr Brain Hlth, Boston, MA 02114 USA
[8] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA
基金
美国国家卫生研究院; 欧盟地平线“2020”;
关键词
CORONARY-ARTERY-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; GENOME-WIDE ASSOCIATION; SMALL VESSEL DISEASE; MENDELIAN RANDOMIZATION; ISCHEMIC-STROKE; HEART-DISEASE; INTRACEREBRAL HEMORRHAGE; CARDIOVASCULAR-DISEASE; UP-REGULATION;
D O I
10.1016/S1474-4422(19)30043-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Stroke, a leading cause of long-term disability and death worldwide, has a heritable component. Recent gene discovery efforts have expanded the number of known single-gene disorders associated with stroke and have linked common variants at approximately 35 genetic loci to stroke risk. These discoveries have highlighted novel mechanisms and pathways implicated in stroke related to large artery atherosclerosis, cardioembolism, and small vessel disease, and defined shared genetic influences with related vascular traits. Genetics has also successfully established causal relationships with risk factors and holds promise for prioritising targets for exploration in clinical trials. Genome-wide polygenic scores enable the identification of high-risk individuals before the emergence of vascular risk factors. Challenges ahead include a better understanding of rare variants and ancestral differences for integration of genetics into precision medicine, integration with other omics data, uncovering the genetic factors that govern stroke recurrence and stroke outcome, and the conversion of genetic discoveries to novel therapies.
引用
收藏
页码:587 / 599
页数:13
相关论文
共 50 条
  • [21] A stroke of insight from genetics
    Visscher, Peter M.
    Veldink, Jan H.
    LANCET NEUROLOGY, 2016, 15 (07) : 653 - 654
  • [22] Clinical Neurogenetics: Stroke
    Rost, Natalia S.
    NEUROLOGIC CLINICS, 2013, 31 (04) : 915 - +
  • [23] New Information on the Genetics of Stroke
    Meschia, James F.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2011, 11 (01) : 35 - 41
  • [24] Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
    Eslam, Mohammed
    George, Jacob
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (01) : 40 - 52
  • [25] Transdermal delivery of glyceryl trinitrate: clinical applications in acute stroke
    Appleton, Jason P.
    Krishnan, Kailash
    Bath, Philip M.
    EXPERT OPINION ON DRUG DELIVERY, 2020, 17 (03) : 297 - 303
  • [26] Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke
    Montaner, Joan
    Ramiro, Laura
    Simats, Alba
    Tiedt, Steffen
    Makris, Konstantinos
    Jickling, Glen C.
    Debette, Stephanie
    Sanchez, Jean-Charles
    Bustamante, Alejandro
    NATURE REVIEWS NEUROLOGY, 2020, 16 (05) : 247 - 264
  • [27] Genetics of stroke
    Fornage, Myriam
    CURRENT ATHEROSCLEROSIS REPORTS, 2009, 11 (03) : 167 - 174
  • [28] Genetics of stroke
    Guo, Jin-min
    Liu, Ai-jun
    Su, Ding-feng
    ACTA PHARMACOLOGICA SINICA, 2010, 31 (09) : 1055 - 1064
  • [29] Genetics of stroke
    Jin-min Guo
    Ai-jun Liu
    Ding-feng Su
    Acta Pharmacologica Sinica, 2010, 31 : 1055 - 1064
  • [30] Genetics of stroke
    Myriam Fornage
    Current Atherosclerosis Reports, 2009, 11 : 167 - 174